1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with nafazatrom in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (nafazatrom) | Trials (nafazatrom) | Recent Studies (post-2010) (nafazatrom) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 92 | 5 | 0 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | nafazatrom (IC50) |
---|---|---|---|
Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | 6.1667 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moodley, I; Stuttle, A | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and nafazatrom
Article | Year |
---|---|
Evidence for a dual pathway in platelet activating factor-induced aggregation of rat polymorphonuclear leucocytes.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Cell Aggregation; In Vitro Techniques; Leukotriene B4; Lipoxygenase Inhibitors; Male; Neutrophils; Platelet Activating Factor; Pyrazoles; Pyrazolones; Rats; Rats, Inbred Strains | 1987 |